BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

338 related articles for article (PubMed ID: 11806197)

  • 1. [Moxifloxacin--a novel antimicrobial preparation for treatment of respiratory infections].
    Iakovlev SV; Polushkina NR; Iakovlev VP
    Ter Arkh; 2001; 73(11):15-22. PubMed ID: 11806197
    [No Abstract]   [Full Text] [Related]  

  • 2. Clinical perspectives on new antimicrobials: focus on fluoroquinolones.
    Talan DA
    Clin Infect Dis; 2001 Mar; 32 Suppl 1():S64-71. PubMed ID: 11249831
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Moxifloxacin (Avelox) for the treatment of bacterial skin infections.
    Parish LC; Witkowski JA; Routh HB
    Skin Therapy Lett; 2001 Oct; 6(11):1-2. PubMed ID: 11719825
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of the clinical microbiology profile of moxifloxacin.
    Krasemann C; Meyer J; Tillotson G
    Clin Infect Dis; 2001 Mar; 32 Suppl 1():S51-63. PubMed ID: 11249830
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Respiratory tract infections. Increasingly more established antibiotics fail].
    MMW Fortschr Med; 2002 Oct; 144(42):65. PubMed ID: 12534005
    [No Abstract]   [Full Text] [Related]  

  • 6. Current challenges in the treatment of complicated urinary tract infections and prostatitis.
    Wagenlehner FM; Naber KG
    Clin Microbiol Infect; 2006 May; 12 Suppl 3():67-80. PubMed ID: 16669930
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Moxifloxacin: results of clinical use].
    Iakovlev VP; Polushkina NR
    Antibiot Khimioter; 2002; 47(10):32-6. PubMed ID: 12674792
    [No Abstract]   [Full Text] [Related]  

  • 8. [Novel antibiotics active against Gram-positive bacteria].
    Garcia Sánchez JE; Fresnadillo Martínez MJ
    Rev Esp Quimioter; 2000 Dec; 13(4):344-51. PubMed ID: 11498700
    [No Abstract]   [Full Text] [Related]  

  • 9. [Treatment of lower respiratory tract infections in elderly].
    Iakovlev SV
    Ter Arkh; 1997; 69(12):57-63. PubMed ID: 9503539
    [No Abstract]   [Full Text] [Related]  

  • 10. Moxifloxacin: a review of its clinical potential in the management of community-acquired respiratory tract infections.
    Balfour JA; Lamb HM
    Drugs; 2000 Jan; 59(1):115-39. PubMed ID: 10718103
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An updated safety profile of moxifloxacin.
    Iannini PB; Mandell LA
    J Chemother; 2002 Feb; 14 Suppl 2():29-34. PubMed ID: 12003138
    [No Abstract]   [Full Text] [Related]  

  • 12. Moxifloxacin: a review of the microbiological, pharmacological, clinical and safety features.
    Blondeau JM; Hansen GT
    Expert Opin Pharmacother; 2001 Feb; 2(2):317-35. PubMed ID: 11336589
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Moxifloxacin (Avelox): an 8-methoxyquinolone antibacterial with enhanced potency.
    Ball P
    Int J Clin Pract; 2000 Jun; 54(5):329-32. PubMed ID: 10954961
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Moxifloxacin Bayer.
    Barrett JF
    Curr Opin Investig Drugs; 2000 Sep; 1(1):45-51. PubMed ID: 11249594
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics and pharmacodynamics of fluoroquinolones in the respiratory tract.
    Wise R; Honeybourne D
    Eur Respir J; 1999 Jul; 14(1):221-9. PubMed ID: 10489856
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chronic bacterial prostatitis and relapsing Enterococcus faecalis bacteraemia successfully treated with moxifloxacin.
    van Nieuwkoop C; Visser LG; Groeneveld JH; Kuijper EJ
    J Infect; 2008 Feb; 56(2):155-6. PubMed ID: 18083235
    [No Abstract]   [Full Text] [Related]  

  • 17. [New fluoroquinolones: levofloxacin, moxifloxacin and gatifloxacin].
    van der Eerden MM; Boersma WG
    Ned Tijdschr Geneeskd; 2005 Jan; 149(2):109-10; author reply 110. PubMed ID: 15688848
    [No Abstract]   [Full Text] [Related]  

  • 18. Criteria for use of ofloxacin and lomefloxacin in adult inpatients and outpatients.
    Spivey IM
    Clin Pharm; 1993 Jun; 12(6):452-8. PubMed ID: 8403817
    [No Abstract]   [Full Text] [Related]  

  • 19. In vitro activity of moxifloxacin against Stenotrophomonas maltophilia blood isolates from patients with hematologic malignancies.
    Venditti M; Monaco M; Micozzi A; Tarasi A; Friedrich A; Martino P
    Clin Microbiol Infect; 2001 Jan; 7(1):37-9. PubMed ID: 11284945
    [No Abstract]   [Full Text] [Related]  

  • 20. [Cefotaxime (klaforan) in modern therapy of bacterial infections].
    Khess R; Budanov SV
    Antibiot Khimioter; 1996 Mar; 41(3):44-56. PubMed ID: 8967803
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 17.